Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.

Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW Jr, Pitt ML, Estep J, Davis K.

Clin Infect Dis. 1995 Oct;21 Suppl 2:S178-81. Review.

PMID:
8845449
2.

Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.

Anderson GW Jr, Worsham PL, Bolt CR, Andrews GP, Welkos SL, Friedlander AM, Burans JP.

Am J Trop Med Hyg. 1997 Apr;56(4):471-3.

PMID:
9158060
3.
4.

Construction of defined F1 negative mutants of virulent Yersinia pestis.

Worsham PL, Stein MP, Welkos SL.

Contrib Microbiol Immunol. 1995;13:325-8. No abstract available.

PMID:
8833864
5.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.

Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2012;6(2):e1528. doi: 10.1371/journal.pntd.0001528. Epub 2012 Feb 14.

PMID:
22348169
6.

Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.

Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW.

Microb Pathog. 1997 Sep;23(3):167-79.

PMID:
9281474
7.

Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague.

Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, Tighe M, Harmsen A, Becker T, Crist K, Walters N, Avci R, Pascual DW.

J Immunol. 2007 Jan 15;178(2):1059-67.

PMID:
17202369
8.

Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.

Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29.

PMID:
14522457
9.

Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.

Anisimov AP, Shaikhutdinova RZ, Pan'kina LN, Feodorova VA, Savostina EP, Bystrova OV, Lindner B, Mokrievich AN, Bakhteeva IV, Titareva GM, Dentovskaya SV, Kocharova NA, Senchenkova SN, Holst O, Devdariani ZL, Popov YA, Pier GB, Knirel YA.

J Med Microbiol. 2007 Apr;56(Pt 4):443-53.

PMID:
17374882
11.

[The results of the measured oral infection of white mice with strains of the causative agent of plague differing in their plasmid profile].

Kokushkin AM, Donskaia TN, Salabuda MP, Kushnerev IuF, Chekashov VN, Shcherbakov AA, Marysaev VB.

Zh Mikrobiol Epidemiol Immunobiol. 1994 Jan-Feb;(2):15-20. Russian.

PMID:
8017118
12.

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.

Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.

Vaccine. 2008 Mar 20;26(13):1616-25. doi: 10.1016/j.vaccine.2008.01.033. Epub 2008 Feb 6.

PMID:
18304706
13.

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B.

Infect Immun. 2003 Jan;71(1):374-83.

PMID:
12496187
14.

T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.

Levy Y, Flashner Y, Tidhar A, Zauberman A, Aftalion M, Lazar S, Gur D, Shafferman A, Mamroud E.

Vaccine. 2011 Sep 16;29(40):6866-73. doi: 10.1016/j.vaccine.2011.07.059. Epub 2011 Jul 29.

PMID:
21803090
15.

Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence.

Welkos SL, Andrews GP, Lindler LE, Snellings NJ, Strachan SD.

Plasmid. 2004 Jan;51(1):1-11.

PMID:
14711524
16.
17.

Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

Simpson WJ, Thomas RE, Schwan TG.

Am J Trop Med Hyg. 1990 Oct;43(4):389-96.

PMID:
2240367
18.

Genome sequence of Yersinia pestis, the causative agent of plague.

Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Basham D, Bentley SD, Brooks K, Cerdeño-Tárraga AM, Chillingworth T, Cronin A, Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG.

Nature. 2001 Oct 4;413(6855):523-7.

PMID:
11586360
19.

Role of the virulence-associated plasmids of Yersinia enterocolitica on its immunogenicity against Y. pestis.

Mazigh D, Quilici ML, Mollaret HH.

Ann Microbiol (Paris). 1984 Nov-Dec;135B(3):283-90.

PMID:
6532281
20.

Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis.

Ivanov MI, Noel BL, Rampersaud R, Mena P, Benach JL, Bliska JB.

Infect Immun. 2008 Nov;76(11):5181-90. doi: 10.1128/IAI.00189-08. Epub 2008 Sep 2.

PMID:
18765742

Supplemental Content

Support Center